{
    "2021-04-05": [
        [
            {
                "time": "2021-03-25",
                "original_text": "Johnson & Johnson Given Control of Emergent BioSolutions Factory That Botched Its Coronavirus Vaccine",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Emergent BioSolutions",
                        "Coronavirus Vaccine",
                        "Botched"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-24",
                "original_text": "The IBD/TIPP Poll Gives These 3 Covid Vaccine Stocks Reason To Be Bullish",
                "features": {
                    "keywords": [
                        "IBD/TIPP Poll",
                        "Covid Vaccine Stocks",
                        "Bullish"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-23",
                "original_text": "Travel boom poses threat to COVID-19 recovery: Doctor",
                "features": {
                    "keywords": [
                        "Travel boom",
                        "COVID-19 recovery",
                        "Doctor"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "travel"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-22",
                "original_text": "UPDATE 1-White House says removal of AstraZeneca vaccine from U.S. plant will not affect dose output",
                "features": {
                    "keywords": [
                        "White House",
                        "AstraZeneca",
                        "vaccine",
                        "U.S. plant",
                        "dose output"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-21",
                "original_text": "Johnson & Johnson Becomes Third Company To Expand COVID-19 Vaccine Study To Adolescents",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "COVID-19 Vaccine",
                        "Adolescents"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-20",
                "original_text": "White House's removal of AstraZeneca COVID-19 shot production from Emergent plant won't affect its dose output - official",
                "features": {
                    "keywords": [
                        "White House",
                        "AstraZeneca",
                        "COVID-19 shot",
                        "Emergent plant",
                        "dose output"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-19",
                "original_text": "Emergent (EBS) Gets Extra $23M for COVID-19 Vaccine Production",
                "features": {
                    "keywords": [
                        "Emergent",
                        "EBS",
                        "COVID-19 Vaccine",
                        "Production",
                        "$23M"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-18",
                "original_text": "U.S. COVID vaccine program speeds up to about 3 million doses a day in the past week",
                "features": {
                    "keywords": [
                        "U.S.",
                        "COVID vaccine program",
                        "speeds up",
                        "3 million doses",
                        "past week"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-17",
                "original_text": "J&J Will Manufacture Its Own Vaccine at Emergent Facility Where Doses Were Ruined",
                "features": {
                    "keywords": [
                        "J&J",
                        "Vaccine",
                        "Emergent Facility",
                        "Doses Ruined"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-16",
                "original_text": "SpringWorks (SWTX) Begins Dosing in Multiple Myeloma Study",
                "features": {
                    "keywords": [
                        "SpringWorks",
                        "SWTX",
                        "Multiple Myeloma Study",
                        "Dosing"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "Cidara Therapeutics Stock Rises After Collaboration Agreement Janssen For Influenza Candidates",
                "features": {
                    "keywords": [
                        "Cidara Therapeutics",
                        "Stock Rises",
                        "Collaboration Agreement",
                        "Janssen",
                        "Influenza Candidates"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-14",
                "original_text": "Is J&J Stock A Buy Now That The FDA Has Authorized Its Covid Vaccine?",
                "features": {
                    "keywords": [
                        "J&J Stock",
                        "FDA",
                        "Authorized",
                        "Covid Vaccine"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-13",
                "original_text": "Emergent BioSolutions' Plasma-Based Therapy Candidate Flunks COVID-19 Study; HHS Increases Task Order By $23M",
                "features": {
                    "keywords": [
                        "Emergent BioSolutions",
                        "Plasma-Based Therapy",
                        "COVID-19 Study",
                        "HHS",
                        "$23M"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-12",
                "original_text": "J&J (JNJ) Gets Full Charge of Emergent COVID-19 Vaccine Plant",
                "features": {
                    "keywords": [
                        "J&J",
                        "JNJ",
                        "Emergent",
                        "COVID-19 Vaccine Plant"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-11",
                "original_text": "Emergent BioSolutions says on track with COVID vaccines, reaffirms guidance after J&J vaccine snafu",
                "features": {
                    "keywords": [
                        "Emergent BioSolutions",
                        "COVID vaccines",
                        "J&J vaccine snafu"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-10",
                "original_text": "I'm Buying Arcturus Therapeutics Stock and Here's the Reason Why",
                "features": {
                    "keywords": [
                        "Arcturus Therapeutics",
                        "Buying",
                        "Stock"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-09",
                "original_text": "Vaccine Stocks Checkup: Johnson & Johnson, Pfizer Update",
                "features": {
                    "keywords": [
                        "Vaccine Stocks",
                        "Johnson & Johnson",
                        "Pfizer",
                        "Update"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-08",
                "original_text": "Covid-19 Vaccine Update And Outlook Amid New Variants, Hiccups For Some Vaccine Developers",
                "features": {
                    "keywords": [
                        "Covid-19 Vaccine",
                        "Update",
                        "Outlook",
                        "New Variants",
                        "Vaccine Developers"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-07",
                "original_text": "Emergent gets $23 mln additional order for vaccine production",
                "features": {
                    "keywords": [
                        "Emergent",
                        "$23 mln",
                        "vaccine production"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}